A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis (Q43508439)

24 November 2017

A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis (English)

1 reference

24 November 2017

Michitaka Kohashi

1

1 reference

24 November 2017

Shin Nishiumi

2

1 reference

24 November 2017

Makoto Ooi

3

1 reference

24 November 2017

Tomoo Yoshie

4

1 reference

24 November 2017

Atsuki Matsubara

5

1 reference

24 November 2017

Makoto Suzuki

6

1 reference

24 November 2017

Namiko Hoshi

7

1 reference

24 November 2017

Koji Kamikozuru

8

1 reference

24 November 2017

Yoko Yokoyama

9

1 reference

24 November 2017

Ken Fukunaga

10

1 reference

24 November 2017

Shiro Nakamura

11

1 reference

24 November 2017

Takeshi Azuma

12

1 reference

24 November 2017

Masaru Yoshida

13

1 reference

24 November 2017

26 February 2014

1 reference

Journal of Crohn's and Colitis

24 November 2017

1 reference

24 November 2017

8

1 reference

24 November 2017

9

1 reference

24 November 2017

1010-1021

1 reference

Inflammatory bowel disease in Asia: A systematic review

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Familial occurrence of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

A novel serum metabolomics-based diagnostic approach for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Statistical tests for differential expression in cDNA microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

IBD serological panels: facts and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Advances in clinical laboratory tests for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Identification of a novel bacterial sequence associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Bacterial flagellin is a dominant antigen in Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Hyperhomocysteinemia in ulcerative colitis is related to folate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Vascular complications of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.024

10.1016/J.CROHNS.2014.01.024

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference